197 related articles for article (PubMed ID: 28114575)
1. HTRA1 and TGF-β1 Concentrations in the Aqueous Humor of Patients With Neovascular Age-Related Macular Degeneration.
Tosi GM; Caldi E; Neri G; Nuti E; Marigliani D; Baiocchi S; Traversi C; Cevenini G; Tarantello A; Fusco F; Nardi F; Orlandini M; Galvagni F
Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):162-167. PubMed ID: 28114575
[TBL] [Abstract][Full Text] [Related]
2. Aqueous humor cytokine levels in patients with polypoidal choroidal vasculopathy and neovascular age-related macular degeneration.
Sakurada Y; Nakamura Y; Yoneyama S; Mabuchi F; Gotoh T; Tateno Y; Sugiyama A; Kubota T; Iijima H
Ophthalmic Res; 2015; 53(1):2-7. PubMed ID: 25472810
[TBL] [Abstract][Full Text] [Related]
3. ANGIOPOIETIN-LIKE 4 CORRELATES WITH RESPONSE TO INTRAVITREAL RANIBIZUMAB INJECTIONS IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
Kim JH; Shin JP; Kim IT; Park DH
Retina; 2018 Mar; 38(3):523-530. PubMed ID: 28151839
[TBL] [Abstract][Full Text] [Related]
4. Intraocular Vascular Endothelial Growth Factor Levels in Pachychoroid Neovasculopathy and Neovascular Age-Related Macular Degeneration.
Hata M; Yamashiro K; Ooto S; Oishi A; Tamura H; Miyata M; Ueda-Arakawa N; Takahashi A; Tsujikawa A; Yoshimura N
Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):292-298. PubMed ID: 28114590
[TBL] [Abstract][Full Text] [Related]
5. Dynamics of Inflammatory Factors in Aqueous Humor during Ranibizumab or Aflibercept Treatment for Age-Related Macular Degeneration.
Motohashi R; Noma H; Yasuda K; Kotake O; Goto H; Shimura M
Ophthalmic Res; 2017; 58(4):209-216. PubMed ID: 28796997
[TBL] [Abstract][Full Text] [Related]
6. Aqueous humor levels of vascular endothelial growth factor before and after intravitreal bevacizumab in type 3 versus type 1 and 2 neovascularization. A prospective, case-control study.
dell'Omo R; Cassetta M; dell'Omo E; di Salvatore A; Hughes JM; Aceto F; Porcellini A; Costagliola C
Am J Ophthalmol; 2012 Jan; 153(1):155-61.e2. PubMed ID: 21861975
[TBL] [Abstract][Full Text] [Related]
7. Neovascular age-related macular degeneration: intraocular cytokines and growth factors and the influence of therapy with ranibizumab.
Funk M; Karl D; Georgopoulos M; Benesch T; Sacu S; Polak K; Zlabinger GJ; Schmidt-Erfurth U
Ophthalmology; 2009 Dec; 116(12):2393-9. PubMed ID: 19815292
[TBL] [Abstract][Full Text] [Related]
8. TGF-β concentrations and activity are down-regulated in the aqueous humor of patients with neovascular age-related macular degeneration.
Tosi GM; Neri G; Caldi E; Fusco F; Bacci T; Tarantello A; Nuti E; Marigliani D; Baiocchi S; Traversi C; Barbarino M; Eandi CM; Parolini B; Mundo L; Santucci A; Orlandini M; Galvagni F
Sci Rep; 2018 May; 8(1):8053. PubMed ID: 29795291
[TBL] [Abstract][Full Text] [Related]
9. Aqueous vascular endothelial growth factor and ranibizumab concentrations after monthly and bimonthly intravitreal injections of ranibizumab for age-related macular degeneration.
Wang X; Sawada T; Kakinoki M; Miyake T; Kawamura H; Saishin Y; Liu P; Ohji M
Graefes Arch Clin Exp Ophthalmol; 2014 Jul; 252(7):1033-9. PubMed ID: 24196779
[TBL] [Abstract][Full Text] [Related]
10. Glucose Metabolic Characterization of Human Aqueous Humor in Relation to Wet Age-Related Macular Degeneration.
Han G; Wei P; He M; Teng H
Invest Ophthalmol Vis Sci; 2020 Mar; 61(3):49. PubMed ID: 32232346
[TBL] [Abstract][Full Text] [Related]
11. The Intraocular Cytokine Profile and Therapeutic Response in Persistent Neovascular Age-Related Macular Degeneration.
Rezar-Dreindl S; Sacu S; Eibenberger K; Pollreisz A; Bühl W; Georgopoulos M; Krall C; Weigert G; Schmidt-Erfurth U
Invest Ophthalmol Vis Sci; 2016 Aug; 57(10):4144-50. PubMed ID: 27537264
[TBL] [Abstract][Full Text] [Related]
12. Aqueous vascular endothelial growth factor after intravitreal injection of pegaptanib or ranibizumab in patients with age-related macular degeneration.
Sawada O; Miyake T; Kakinoki M; Sawada T; Kawamura H; Ohji M
Retina; 2010; 30(7):1034-8. PubMed ID: 20616682
[TBL] [Abstract][Full Text] [Related]
13. Cytokine and Chemokine Profile Changes in Patients with Neovascular Age-Related Macular Degeneration After Intravitreal Ranibizumab Injection for Choroidal Neovascularization.
Sun T; Wei Q; Gao P; Zhang Y; Peng Q
Drug Des Devel Ther; 2021; 15():2457-2467. PubMed ID: 34140764
[TBL] [Abstract][Full Text] [Related]
14. Highly Expressed Amyloid Beta-42 Of Aqueous Humor In Patients With Neovascular Macular Degeneration.
Zhu J; Su T; Wang M; Li M; Liu L; Wang F
Semin Ophthalmol; 2021 Feb; 36(1-2):9-13. PubMed ID: 33587673
[No Abstract] [Full Text] [Related]
15. Vascular endothelial growth factor in patients with exudative age-related macular degeneration treated with ranibizumab.
Muether PS; Hermann MM; Viebahn U; Kirchhof B; Fauser S
Ophthalmology; 2012 Oct; 119(10):2082-6. PubMed ID: 22920670
[TBL] [Abstract][Full Text] [Related]
16. Changes in aqueous vascular endothelial growth factor and pigment epithelium-derived factor after ranibizumab alone or combined with verteporfin for exudative age-related macular degeneration.
Ahn JK; Moon HJ
Am J Ophthalmol; 2009 Nov; 148(5):718-724.e1. PubMed ID: 19674731
[TBL] [Abstract][Full Text] [Related]
17. Assessment of Choroidal Topographic Changes by Swept-Source Optical Coherence Tomography After Intravitreal Ranibizumab for Exudative Age-Related Macular Degeneration.
Razavi S; Souied EH; Darvizeh F; Querques G
Am J Ophthalmol; 2015 Nov; 160(5):1006-13. PubMed ID: 26275471
[TBL] [Abstract][Full Text] [Related]
18. A randomized trial to compare the safety and efficacy of two ranibizumab dosing regimens in a Turkish cohort of patients with choroidal neovascularization secondary to AMD.
Eldem BM; Muftuoglu G; Topbaş S; Çakir M; Kadayifcilar S; Özmert E; Bahçecioğlu H; Sahin F; Sevgi S;
Acta Ophthalmol; 2015 Sep; 93(6):e458-64. PubMed ID: 25160859
[TBL] [Abstract][Full Text] [Related]
19. Profile of intraocular immune mediators in patients with age-related macular degeneration and the effect of intravitreal bevacizumab injection.
Agawa T; Usui Y; Wakabayashi Y; Okunuki Y; Juan M; Umazume K; Kezuka T; Takeuchi M; Yamauchi Y; Goto H
Retina; 2014 Sep; 34(9):1811-8. PubMed ID: 24801651
[TBL] [Abstract][Full Text] [Related]
20. Changes in Neovascular Lesion Hyperreflectivity After Anti-VEGF Treatment in Age-Related Macular Degeneration: An Integrated Multimodal Imaging Analysis.
Casalino G; Bandello F; Chakravarthy U
Invest Ophthalmol Vis Sci; 2016 Jul; 57(9):OCT288-98. PubMed ID: 27409485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
